Thursday, October 25, 2007

Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and ... (PR Newswire via Yahoo! Finance)

Cell Therapeutics, Inc. and Systems Medicine, LLC , a wholly-owned subsidiary of CTI, announced that preclinical data presented at the 19th annual AACR-NCI-EORTC Symposium show an antibody to IGF-II may solve the problems of low blood sugar associated with drug candidates working through insulin receptor-linked pathways.


[Source: Yahoo! News Search Results for testicular cancer]

No comments: